HPV-associated squamous cell carcinoma of the penis is a type of penile cancer caused by a long-lasting infection with high-risk human papillomavirus (HPV). It starts from the squamous cells that cover the surface of the penis, most often on the glans (the head of the penis) or the inner foreskin. Between one-third and one-half of penile cancers are HPV-associated. The rest are HPV-independent squamous cell carcinomas that develop for other reasons.
This article explains how HPV-associated squamous cell carcinoma of the penis is diagnosed and what the findings in your pathology report mean. These findings include the tumor type, p16 result, grade, depth of invasion, margins, lymph nodes, and stage.
Penile cancer is uncommon in North America and Europe, affecting about 1 in 100,000 men each year. It is much more common in parts of South America, Southeast Asia, and Africa. Most men are diagnosed in their 50s or 60s, but HPV-associated penile cancer can also affect younger men.
HPV-associated squamous cell carcinoma of the penis is caused by a long-lasting infection with a high-risk type of HPV, most often HPV type 16. High-risk HPV is a common virus that spreads through sexual contact. Most HPV infections clear on their own. In a small number of men, the infection persists, and the virus produces proteins that prevent infected cells from controlling their growth.
Over time, these cells can form a precancerous change called penile intraepithelial neoplasia (PeIN). If PeIN is not treated, it can develop into invasive cancer. Other factors linked with penile cancer include a tight foreskin that cannot be pulled back, called phimosis, and smoking.
The most common symptom of penile cancer is a sore, lump, or patch on the glans or foreskin that does not heal. The area may bleed, have a bad-smelling discharge, or change color. When the cancer is hidden under a tight foreskin, it may first be noticed as swelling or discharge. Some men notice enlarged lymph nodes in the groin, which can be a sign that the cancer has spread.
The diagnosis of HPV-associated squamous cell carcinoma of the penis usually begins with a small sample of tissue from the abnormal area, taken in a procedure called a biopsy. The tumor may later be removed by circumcision, by removing the glans, or by removing part or all of the penis, depending on its size and location.
A pathologist examines the tissue under the microscope. The pathologist looks for abnormal squamous cells that have broken through the surface layer and grown into the tissue below, a process called invasion. HPV-associated tumors often consist of small, dark-blue cells that produce little keratin, the tough protein normally found in skin. They are described as nonkeratinizing or only partly keratinizing.
To confirm the tumor is HPV-associated, the pathologist usually stains for a protein called p16, described below. Once cancer is confirmed, the groin lymph nodes are examined, and imaging such as CT, MRI, or ultrasound may be used to check for spread.
p16 is a protein that builds up in cells infected with high-risk HPV. Pathologists test for p16 using immunohistochemistry, a test that uses antibodies to show which proteins cells make. Current European and American guidelines (EAU-ASCO, 2026) recommend that every penile squamous cell carcinoma report include a p16 result. Your report will describe p16 in one of these ways:
Some laboratories also test directly for HPV using a method called in situ hybridization (ISH). A positive result confirms that high-risk HPV is present in the tumor cells. Not every laboratory performs this test, and p16 alone is usually enough.
The World Health Organization (WHO) classification, 5th edition (2022), divides HPV-associated squamous cell carcinoma of the penis into several types. The type is based on how the tumor looks under the microscope, and some types behave differently. Your report may name one of these types:
Older reports may use the term lymphoepithelioma-like carcinoma for lymphoepithelial carcinoma. When p16 or HPV testing is not available, the report may say squamous cell carcinoma, not otherwise specified (NOS).
The histologic grade of HPV-associated squamous cell carcinoma of the penis describes how different the tumor cells look from normal squamous cells. Pathologists use the three-tier WHO/ISUP grading system and grade the tumor by its least differentiated part:
Grade matters because a grade 3 tumor that is otherwise stage pT1 is staged as pT1b rather than pT1a. Basaloid carcinoma is usually high grade. Grade can be difficult to judge in a small biopsy, so the grade may change after the whole tumor is removed.
Depth of invasion describes how far HPV-associated squamous cell carcinoma has grown below the surface of the penis. The pathologist measures it in millimeters. The report also names the deepest layer of tissue the tumor has reached:
Deeper tumors are more likely to spread to lymph nodes, and the deepest layer reached decides the tumor stage (pT).
Perineural invasion means tumor cells were seen along or inside a nerve. Nerves can act as a pathway for tumor cells to spread. Your report will describe perineural invasion as present, not identified, or cannot be determined. In HPV-associated squamous cell carcinoma of the penis, perineural invasion raises the stage of a pT1 tumor from pT1a to pT1b. It is also linked with a higher chance of spread to lymph nodes.
Lymphovascular invasion means tumor cells were seen inside a blood vessel or lymphatic channel. Lymphatic channels drain to the groin lymph nodes, so tumor cells within them have a route to spread. Your report will describe lymphovascular invasion as present, not identified, or cannot be determined. Like perineural invasion, lymphovascular invasion upstages a pT1 tumor to pT1b. It is one of the strongest predictors of lymph node spread.
Penile intraepithelial neoplasia, or PeIN, is the precancerous change from which HPV-associated squamous cell carcinoma usually develops. In PeIN, abnormal squamous cells fill the surface layer but have not invaded the tissue below. PeIN is often found in the skin next to the invasive tumor.
Your report may describe the PeIN as basaloid, warty, or warty-basaloid, matching the HPV-associated types of invasive cancer. PeIN next to the tumor does not change the stage. It matters for margins because PeIN left at a cut edge can recur.
A margin is the cut edge of tissue removed during surgery. For HPV-associated squamous cell carcinoma of the penis, the report describes margins separately for invasive carcinoma and for PeIN. Margins your report may name include the urethral margin, the corpus cavernosum and corpus spongiosum margins, and the skin or mucosal margins. Your report will describe the margins in one of these ways:
Studies show that the chance of the cancer coming back in the same place rises considerably when the tumor is less than 1 mm from the margin.
Lymph nodes are small immune organs found throughout the body. Penile cancer usually spreads first to the lymph nodes in the groin, called the inguinal lymph nodes, and then to the lymph nodes in the pelvis. The lymph node result is the most important factor for prognosis in penile cancer.
When the groin lymph nodes feel normal, the care team may remove only the first one or two lymph nodes that drain the tumor. This is called a sentinel lymph node biopsy. If the lymph nodes are enlarged, the surgeon may perform a larger operation called an inguinal lymph node dissection. The pathologist reports:
Our article on sentinel lymph node biopsy reports explains this procedure in more detail.
For most men with HPV-associated squamous cell carcinoma of the penis, no biomarker test currently guides selection of a specific targeted drug. The p16 test described above is used to classify the tumor and to estimate prognosis, not to choose a drug. In advanced penile cancer, comprehensive next-generation sequencing (NGS) testing may be performed. This testing can find changes such as mismatch repair deficiency or a high tumor mutational burden. These are rare in penile cancer, but they can make a patient eligible for treatments approved across many cancer types in some countries. Your oncologist can tell you whether this testing is right for you. Our Biomarkers and Genetic Testing section explains these tests in more detail.
The pathologic stage of HPV-associated squamous cell carcinoma of the penis is based on the tumor (pT) and any lymph nodes examined (pN). It uses the TNM staging system in the 8th edition of the AJCC Cancer Staging Manual. Spread to distant organs (M) is usually determined by imaging, not by the pathologist.
The prognosis for HPV-associated squamous cell carcinoma of the penis depends mainly on whether the cancer has spread to lymph nodes. In large US registry data, about 81 in 100 people with penile cancer limited to the penis are alive five years later. This falls to about 16 in 100 when the cancer has spread to distant organs. In one study, about 62 in 100 men without pelvic lymph node spread were alive five years later. This fell to about 17 in 100 when the pelvic lymph nodes contained cancer.
HPV-associated tumors generally have a better outlook than HPV-independent tumors. In combined studies, about 88 in 100 men with p16-positive tumors had not died of penile cancer five years later. The figure was about 58 in 100 for men with p16-negative tumors. Warty carcinoma has an especially good outlook, while basaloid carcinoma is more likely to spread. Pathologic features linked with a less favorable outlook include:
After HPV-associated squamous cell carcinoma of the penis is diagnosed, the next steps depend mainly on the stage and the lymph node findings. Care is usually planned by a urologist with experience in penile cancer, often at a specialized center. A medical oncologist and a radiation oncologist may also be involved.
Treatment of the tumor aims to remove the cancer while preserving as much of the penis as possible. For small or superficial tumors, the options may include laser treatment, removal of the surface skin of the glans, or removal of the glans. For larger or deeper tumors, part or all of the penis may need to be removed. Radiation therapy, including internal radiation called brachytherapy, is an option for some small tumors.
The groin lymph nodes are checked even when they feel normal, because penile cancer can spread there without causing a lump. The choice between surveillance, sentinel lymph node biopsy, and lymph node dissection depends on the pathologic findings in your report. When 3 or more lymph nodes on one side contain cancer, or extranodal extension is present, the pelvic lymph nodes may also be removed. For large or fixed lymph nodes, doctors may give chemotherapy that includes cisplatin before surgery.
For penile cancer that has spread to distant organs, chemotherapy that includes a platinum drug is usually considered. Immunotherapy drugs are being studied in clinical trials, and current guidelines encourage people with advanced penile cancer to ask about trials. Your care team can tell you whether any trials are open to you. Follow-up visits continue for several years and include examination of the penis and groins.